(Q45031289)

8 December 2017

title

Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin (English)

1 reference

8 December 2017

L S Czer

1

1 reference

8 December 2017

T M Bateman

2

1 reference

8 December 2017

R J Gray

3

1 reference

8 December 2017

M Raymond

4

1 reference

8 December 2017

M E Stewart

5

1 reference

8 December 2017

S Lee

6

1 reference

8 December 2017

D Goldfinger

7

1 reference

8 December 2017

A Chaux

8

1 reference

8 December 2017

J M Matloff

9

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

Journal of the American College of Cardiology

8 December 2017

published in

1 reference

8 December 2017

volume

9

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

1139-1147

1 reference

Bleeding after cardiopulmonary bypass

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Platelet Dysfunction Associated with Cardiopulmonary Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Coagulation Defects and Bleeding in Open-Heart Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Hemostasis changes during cardiopulmonary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

BLOOD PLATELETS AND EXTRACORPOREAL CIRCULATION

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Platelet kinetics during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

In Vivo Platelet Function Following Cardiopulmonary Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Bleeding in a uremia--a clinical challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Factor VIII concentrate prepared from blood donors stimulated by intranasal administration of a vasopressin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Specificity in the Factor VIII Response to Vasopressin Infusion in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Perioperative myocardial infarction: late clinical course after coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

Percutaneous transluminal coronary angioplasty versus coronary artery bypass. Isn't it time for a randomized trial?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980319-4

7 January 2021

10.1016/S0735-1097(87)80319-4

Identifiers

DOI

1 reference

8 December 2017

1 reference